Abiopharma

🔍 Massaro Michael (Executive)

Company: Flywire Corp (FLYW)

Report Date: 2026-05-06

Detailed Transactions and Holdings:

• Sold 11,830 shares of Voting Common Stock at $15.6543 per share (Direct)
  Date: 2026-05-06 | Code: S | equity_swap_involved: false | shares_owned_after: 2,804,205.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 38,170 shares of Voting Common Stock at $16.6229 per share (Direct)
  Date: 2026-05-06 | Code: S | equity_swap_involved: false | shares_owned_after: 2,766,035.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Holds 0 shares of Voting Common Stock (Direct)
  Date: 2026-05-06 | Code: H | nature_of_ownership: See footnote | shares_owned_after: 192,193.00 | Footnotes: F4
• Holds 0 shares of Voting Common Stock (Direct)
  Date: 2026-05-06 | Code: H | nature_of_ownership: See footnote | shares_owned_after: 307,548.00 | Footnotes: F5

Footnotes:

• F1: Shares were sold pursuant to a previously adopted Rule 10b5-1 trading plan.
• F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.085 to $16.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote to this Form 4.
• F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.15 to $16.905, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote to this Form 4.
• F4: The shares are held by the M Massaro Trust, of which the Reporting Person's spouse is a trustee. The Reporting Person disclaims beneficial ownership of these shares and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such shares for purposes of Section 16 or for any other purpose, except to the extent of the Reporting Person's pecuniary interests therein, if any.
• F5: The shares are held by the Michael P. Massaro 2021 Irrevocable Trust, of which the Reporting Person's spouse is a trustee. The Reporting Person disclaims beneficial ownership of these shares and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such shares for purposes of Section 16 or for any other purpose, except to the extent of the Reporting Person's pecuniary interests therein, if any.